MedTrace Logo

Reduce Tobacco Use in People Living With HIV in Switzerland

NCT06789692 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 972

Last updated 2025-11-18

No results posted yet for this study

Summary

The purpose of this trial is to test the effectiveness of offering a menu of different tobacco smoking substitutional products (e-cigarettes, nicotine pouches, nicotine patches in addition to usual of care) for smokers in the SHCS (Swiss HIV Cohort Study) in achieving self-reported 7-day tobacco cigarette abstinence at 6 months.

Conditions

Interventions

OTHER

tobacco smoking substitution products

Offer of preference-based smoking substitution menu, consisting of e-cigarettes or nicotine pouches or nicotine patches in addition to standard of care. This menu will be offered by the treating physician during the routine cohort visit and the participant can choose one product to test as an alternative to tobacco smoking. The products will be handed out directly after the consultation and are provided free of charge for 6 months.

Sponsors & Collaborators

  • Swiss National Science Foundation

    collaborator OTHER

  • Novartis Foundation for Medical-Biological Research

    collaborator UNKNOWN

  • University Hospital, Basel, Switzerland

    lead OTHER

Principal Investigators

  • Matthias Briel, Prof. · University Hospital, Basel, Switzerland

  • Alain Amstutz, Dr. · University Hospital, Basel, Switzerland

  • Christof Schönenberger, Dr. · University Hospital, Basel, Switzerland

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-02-20
Primary Completion
2027-12-31
Completion
2027-12-31

Countries

  • Switzerland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06789692 on ClinicalTrials.gov